Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
-
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
-
Forterra Closes $238 Million Series C, Cementing Leadership in Autonomy and Interoperable Systems
-
Brixton Metals Drills 112 g/t Gold Over 0.50m with Visible Gold Within 23.50m of 3.33 g/t Gold at Trapper Target
-
Habit Celebrates “Good Habits Day” with Free Double Charburgers to Support No Kid Hungry
-
PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results
-
FLSmidth & Co. A/S financial calendar for 2026
-
BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates
-
Toobit Launches ITE Trading Conquest Following Presale Sellout
-
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
-
Form 8.3 - Idox Plc
-
Central Bancompany, Inc. Announces Launch of Initial Public Offering
-
Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease
-
Alpha Modus Files Amended Patent Infringement Complaint Against The Kroger Co., Expanding to Nine Patents Covering AI Retail Systems
-
Form 8.3 - Empiric Student Property Plc
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
-
Gilat Reports Third Quarter 2025 Results
-
Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer
-
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
-
Zenas BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Bitdeer Reports Fire Incident at Massillon Development Site
-
Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
-
Bunzl Canada Earns 2025 Great Place to Work® Certification
-
Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests
-
Fancamp Announces New Partnership With Harfang and Initiation of Strategic Corporate Reorganization
-
ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights
-
USA Rare Earth Announces UK Regulatory Approval for Acquisition of Less Common Metals (LCM)
-
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Monogram Health Announces New Executives to Oversee its U.S. Operations
-
Home Resource Becomes Exclusive US Distributor of Kettnaker Soma Media System
-
Bexorg Strengthens Leadership Team with Appointment of Sean Murphy, Ph.D., as Chief Technology Officer
-
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease
-
DAVIDsTEA Announces $3.0 Million Private Placement and $2.7 Million Revenue-Linked Financing
-
SEED Therapeutics Receives IND Clearance from China’s NMPA for ST-01156
-
Opus Genetics Announces Financial Results for Third Quarter 2025 and Provides Corporate Update
-
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
-
Ocular Therapeutix™ to Participate in November and December Investor Conferences
-
Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update
-
BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update
-
GlobalFoundries Reports Third Quarter 2025 Financial Results
-
Goranson Bain Ausley Named #2 Top Workplace in Dallas Morning News 2025 Ranking
-
Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
-
ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights
-
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
-
Prospect Credit REIT Provides $18.0 Million to Class A Stabilized Cash-Flowing Multifamily Property in New Rochelle, NY
-
Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results
-
Amplify ETFs Files for the Amplify HACK Cybersecurity Covered Call ETF (HAKY)
-
AleAnna, Inc. Reports Third Quarter 2025 Results and Provides Update on Longanesi Field
